ALPS Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$501K Sell
4,586
-405
-8% -$38.6K ﹤0.01% 823
2025
Q4
$405K Buy
4,991
+55
+1% +$4.74K ﹤0.01% 887
2025
Q3
$432K Buy
4,936
+664
+16% +$59.3K ﹤0.01% 868
2025
Q2
$355K Buy
4,272
+52
+1% +$4.35K ﹤0.01% 859
2025
Q1
$354K Buy
+4,220
New +$393K ﹤0.01% 769
2022
Q1
Sell
-6,469
Closed -$325K 908
2021
Q4
$325K Buy
6,469
+130
+2% +$6.72K ﹤0.01% 814
2021
Q3
$337K Sell
6,339
-1,206
-16% -$67.9K ﹤0.01% 812
2021
Q2
$460K Hold
7,545
﹤0.01% 529
2021
Q1
$368K Buy
+7,545
New +$354K ﹤0.01% 535
2019
Q3
Sell
-12,775
Closed -$357K 922
2019
Q2
$357K Sell
12,775
-674
-5% -$18.7K ﹤0.01% 766
2019
Q1
$417K Buy
13,449
+249
+2% +$6.64K ﹤0.01% 610
2018
Q4
$312K Sell
13,200
-657
-5% -$17.9K ﹤0.01% 782
2018
Q3
$537K Buy
13,857
+1,434
+12% +$51.7K ﹤0.01% 547
2018
Q2
$416K Sell
12,423
-584
-4% -$20.8K ﹤0.01% 746
2018
Q1
$471K Buy
13,007
+700
+6% +$24.2K ﹤0.01% 593
2017
Q4
$392K Buy
12,307
+1
+0% +$34 ﹤0.01% 683
2017
Q3
$460K Sell
12,306
-8,641
-41% -$294K ﹤0.01% 648
2017
Q2
$654K Buy
20,947
+54
+0.3% +$1.56K ﹤0.01% 314
2017
Q1
$515K Buy
+20,893
New +$491K ﹤0.01% 380

Other funds holding LMAT

ALPS Advisors's LMAT Position: Q1 2026 in Review

ALPS Advisors reduced its LeMaitre Vascular (LMAT) stake by 8.1% in Q1 2026, selling an estimated $38.6K and leaving 4,586 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #823.

ALPS Advisors first reported a position in LMAT in Q1 2017 and has held it in 19 quarters since. The position peaked at $654K in Q2 2017. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • ALPS Advisors held 4,586 shares of LeMaitre Vascular worth $501K as of Q1 2026.
  • ALPS Advisors sold 405 LeMaitre Vascular shares in Q1 2026, an estimated $38.6K.
  • LeMaitre Vascular made up ﹤0.01% of ALPS Advisors's portfolio in Q1 2026, its #823 holding.
  • ALPS Advisors first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 19 quarters since.
  • ALPS Advisors's LeMaitre Vascular position peaked at $654K in Q2 2017.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.